Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lupus
Phenotype C0040053|thrombosis
Sentences 19
PubMedID- 25661833 Subarachnoid hemorrhage and dural sinus thrombosis are important manifestations of neuropsychiatric lupus erythematosus.
PubMedID- 25774325 While in aps (for example aps secondary to lupus) chorea is associated with thrombosis and elevated titers of the lac antibody, pre-aps (our case and those listed in the table) is associated with an increase of acl antibodies and a normal titer of lac (table 1).
PubMedID- 23676348 Introduction: predicting thrombosis in patients with systemic lupus erythematosus (sle) and/or antiphospholipid antibodies (apl) is still challenging.
PubMedID- 25832953 Cerebral venous thrombosis as a complication of neuropsychiatric systemic lupus erythematosus.
PubMedID- 25859362 Accumulating evidence indicates that renal microvascular thrombosis due to lupus anticoagulant is an independent risk factor for poor renal outcome in lupus nephritis [1, 2].
PubMedID- 22341691 A previous thrombosis and the presence of a lupus anticoagulant are risk factors for pregnancy failure.
PubMedID- 25008944 Previous thrombosis, diagnosis of systemic lupus erythematosus (sle) and triple antiphospholipid (apl) antibody positivity have recently been found to be independent factors associated to pregnancy failure during conventional therapy in women with antiphospholipid syndrome (aps).
PubMedID- 26075289 In particular, apl positivity has been identified as one of the main determinants of thrombosis among subjects with systemic lupus erythematosus (sle) [12].
PubMedID- 22193216 Reevaluation of predictive value of acl and anti-beta2gp1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world.
PubMedID- 25672373 Spontaneous coronary artery thrombosis in the setting of active lupus mesenteric vasculitis.
PubMedID- 25117655 We investigated the relationship between tpo and the occurrence of thrombocytopenia and thrombosis in patients with systemic lupus erythematosus (sle).
PubMedID- 19589627 Two patients had a circulating lupus anticoagulant, with portal venous thrombosis following splenectomy in one case.
PubMedID- 25485787 Whether treatment decreases the thrombosis risk due to lupus anticoagulant remains unknown.
PubMedID- 20814493 Due to the availability of magnetic resonance venography the diagnosis of venous sinus thrombosis in patients with lupus is relatively easy these days.
PubMedID- 20182349 Warfarin therapy is used in lupus anticoagulant patients with thrombosis and yet the prothrombin time (pt)/international normalized ratio (inr) in these patients can sometimes be falsely elevated.
PubMedID- 21411997 We briefly review the pathophysiology of acute coronary thrombosis in lupus patients and distinguish this from the more common process of age-related atherosclerosis.
PubMedID- 26090493 Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single-centre experience in china.
PubMedID- 22859353 Hydroxychloroquine (hcq) has been shown in retrospective studies to decrease apl titers in laboratory studies, and to decrease thrombosis risk in patients with systemic lupus erythematosus (sle).
PubMedID- 23877806 Objective: to identify clinical and laboratorial factors associated with the development of arterial or venous thrombosis in patients with sle and lupus nephritis (ln).

Page: 1